Europe Faces Antibiotic Shortage Amid Production Halt

Europe runs out of antibiotics and garlic is not the cure

Are we really going to die from sepsis due to a lack of amoxicillin while cocaine crosses oceans without issue? That is the question hovering when two narratives intersect: pharmaceutical companies stopping medication production because it is unprofitable, and an energy crisis that some claim makes everything more expensive. The antibiotic shortage in Europe is not just forum speculation: countries are buying drugs from neighbors because their industry has stopped producing them.

What is happening with the shortage

The starting point is a documented reality: pharmaceutical companies are ceasing to produce and market certain medications in some countries because they are no longer profitable. Germany, for example, would be buying tamoxifen — a cancer drug — from another country after deciding to stop manufacturing it. This adds to the pediatric cold and pain medication crisis experienced months ago. Currently affected are specific cancer drugs and treatments for chronic patients, such as antihypertensives.

The official explanation cites supply issues, active ingredients, and margins. The narrative circulating in forums adds another layer: if cheap oil ends, transporting raw materials becomes costly and the chain breaks. Some argue that transporting amoxicillin raw materials depends on oil, and without it, "it is not so easy to bring things in."

The oil argument and the cocaine comparison

Here the analysis splits in two. One sector points to the energy crisis explaining everything: without cheap oil, manufacturing and transporting medications becomes a luxury. The pessimistic scenario assumes global logistics become more expensive and margins evaporate.

The sharpest counterargument is an uncomfortable comparison: cocaine requires 270 liters of gasoline per kilo for synthesis and must cross half the American continent and an ocean to reach Spain. It flows through streets without problem. Yet antibiotics will be scarce "because of the energy crisis." The irony writes itself.

Are antibiotics manufactured in Ukraine?

One of the most popular theories in the conversation is geographic: much of the antibiotics consumed by Europe are manufactured in Ukraine. If the conflict with Russia persists, supply suffers. There is no official confirmation of this dependency in the material, but the hypothesis fits the pattern of selective shortages already affecting other products.

What is certain is that antibiotic production is not as simple as brewing beer. Fleming established the penicillin formula, true, but industrializing an active ingredient, guaranteeing its purity, and distributing it with a cold chain is another matter. Those who reduce it to "fermentation" forget that industrial fermentation requires bioreactors, quality control, and licenses.

Grandma's medicine cabinet: garlic, lemon, and oregano

The conversation inevitably drifts toward home remedies. Garlic, lemon, vinegar, honey with onion used in Germany during both world wars, carvacrol from oregano, and thyme as a broad-spectrum antimicrobial. Some defend that carvacrol is superior in certain cases to synthetic antibiotics against resistant bacteria.

It is necessary to separate wheat from chaff: natural antimicrobials exist and are studied, but no homemade preparation replaces a treatment prescribed by a doctor. The anecdote of the German jar of honey and onion is charming; turning it into a health protocol is something else. And here the article cannot be ironic: self-medicating with garlic does not cure sepsis.

The business of scarcity

The underlying suspicion is that of the "scarcity game": creating the problem and offering the solution. It is argued that elites produce the shortage and then sell the way out. Others recall that in four months, 80 million vaccine doses were manufactured, distributed, and administered to 40 million people, and now there is supposedly no capacity to package amoxicillin.

The contrast is powerful. If the machinery worked at that pace for some things, why not for others? The simplest answer is economic: a vaccine has a guaranteed institutional buyer; a two-euro box of amoxicillin does not.

What to do with the leftover half-box

On a practical level, the conversation turns to hoarding. Some keep a box of amoxicillin "just in case," others recall that expired antibiotics still work based on their experience, and some joke about selling it for an apartment if things get like in '39. However, the health recommendation is not to self-medicate or accumulate: the misuse of antibiotics is precisely what generates resistance.

The antibiotic shortage in Europe is a real problem with multiple explanations: margins, logistics, geopolitics, and industrial priorities. The solution is not in the garden. Fine irony: we have spent decades asking not to abuse antibiotics, and now it turns out the industry takes us at our word.